Atlas Trials

Effect of Dapagliflozin Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion

Clinical trial NCT02113241 · COMPLETED

Trial details

NCT number
NCT02113241
Sponsor
University of Guadalajara
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Metabolic Syndrome X
Start date
2014-04-01
Primary completion
2015-05-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.